MLN9708 and Dexamethasone in High Risk Smoldering Multiple Myeloma: A Clinical and Correlative Pilot Study
Withdrawn prior to enrolment
Phase of Trial: Phase II
Latest Information Update: 19 May 2017
At a glance
- Drugs Ixazomib (Primary) ; Dexamethasone
- Indications Multiple myeloma
- Focus Therapeutic Use
- 12 Mar 2014 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 23 May 2013 Status changed from recruiting to not yet recruiting as reported by ClinicalTrials.gov record.
- 17 Aug 2012 New trial record